ARTELO BIOSCIENCES, INC.

ARTL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $1.2M
SG&A Expense $508.3K $110.9K $752 $509 $4.3K
Operating Income $-2.3M $-232.8K $-29.7K $-15.2K $-15.3K
Operating Margin
Interest Expense $2.1K
Pretax Income
Income Tax Expense $0 $0 $0
Net Income $-2.3M $-234.9K $-29.7K $-15.2K $-15.3K
Net Margin
EPS (Basic) $-1.84 $-0.03 $0.00 $0.00 $0.00
EPS (Diluted) $-1.84 $-0.03 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 1.3M 7.6M 7.6M 6.0M
Shares Outstanding (Diluted) 1.3M 1.9M 7.6M 7.6M 6.0M
Dividends Per Share
← Newer Page 2 of 2 Older →